Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / May / Neovascular Glaucoma and Systemic Disease
News Glaucoma Research & Innovations

Neovascular Glaucoma and Systemic Disease

Neovascular glaucoma linked to increased mortality and cardiovascular risk

5/14/2026 3 min read

Share

  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
Objective:

To investigate the association between neovascular glaucoma (NVG) and long-term mortality and cardiovascular events.

Key Findings:
  • NVG is associated with a 70% increase in all-cause mortality.
  • Patients with NVG have significantly elevated risks of myocardial infarction, stroke, and cardiac arrest.
  • 26.6% of NVG patients experienced a three-point major adverse cardiovascular event over 10 years, compared to 15.7% of matched controls.
  • Ten-year mortality for NVG patients is nearly double that of patients with primary open-angle glaucoma (17.1% vs 8.9%).
  • NVG patients with underlying conditions like proliferative diabetic retinopathy or retinal vein occlusion had worse systemic outcomes.
Interpretation:

The findings suggest that NVG may serve as a clinical marker for systemic vascular disease, indicating a need for integrated cardiovascular risk assessment in NVG management.

Limitations:
  • The retrospective design may introduce biases.
  • Reliance on coded data may affect the accuracy of findings.
Conclusion:

NVG should be viewed not only as an ophthalmic condition but also as a potential indicator of systemic health risks, warranting closer collaboration with primary care and cardiology for patient management.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: